2型固有淋巴细胞在变应性鼻炎中的研究现状

江远航; 刘月辉

doi:10.13201/j.issn.2096-7993.2020.04.023

2型固有淋巴细胞在变应性鼻炎中的研究现状

江远航¹,
刘月辉^1,Δ, ,

- 南昌大学第二附属医院耳鼻咽喉头颈外科(南昌，330006)
基金项目:
国家自然科学基金项目(No：81760184)

详细信息

通讯作者: 刘月辉，E-mail：liuyuehuiclark@21cn.com

^△审校者

中图分类号: R765.21

收稿日期: 2019-05-06

刊出日期: 2020-04-05

Current status of research on group 2 innate lymphocytes in allergic rhinitis

JIANG Yuanhang¹,
LIU Yuehui^1,Δ, ,

More Information

Corresponding author: LIU Yuehui, E-mail: liuyuehuiclark@21cn.com

Received Date: 06 May 2019

Publish Date: 05 April 2020

摘要

- 鼻炎，变应性 /
- 2型固有淋巴细胞 /
- 白细胞介素-33
Abstract: Innate lymphoid cells(ILCs) have been found to be involved in innate immune responses in recent years, and one of the subtypes of group 2 innate lymphoid cells is essential for the development of allergic airway inflammation. They are regulated by a variety of protein molecules to express corresponding cytokines and play different roles. This article will briefly describe the immunological properties of current ILC2 and its role in allergic rhinitis.
- rhinitis, allergic /
- group 2 innate lymphoid cells /
- interleukin-33

HTML全文

参考文献(43)

[1]	Vivier E, Artis D, Colonna M, et al. Innate lymphoid cells: 10 years on[J]. Cell, 2018, 174(5): 1054-1066. doi: 10.1016/j.cell.2018.07.017
[2]	Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo[J]. Immunity, 2001, 15(6): 985-995. doi: 10.1016/S1074-7613(01)00243-6
[3]	Moro K, Yamada T, Tanabe M, et al. Innate production of Th2 cytokines by adipose tissue-associated c-Kit⁺Sca-1⁺lymphoid cells[J]. Nature, 2010, 463(7): 540-544.
[4]	Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity[J]. Nature, 2010, 464(9): 1367-1370.
[5]	Price AE, Liang HE, Sullivan BM, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity[J]. Proc Natl Acad Sci USA, 2010, 107(25): 11489-11494. doi: 10.1073/pnas.1003988107
[6]	Mjösberg JM, Trifari S, Crellin NK, et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161[J]. Nat Immunol, 2011, 12(11): 1055-1062. doi: 10.1038/ni.2104
[7]	Ebihara T, Taniuchi I. Transcription factors in the development and function of group 2 innate lymphoid cells[J]. Int J Mol Sci, 2019, 20(6): 1377-1377. doi: 10.3390/ijms20061377
[8]	Tufa DM, Yingst AM, Shank T, et al. Transient expression of GATA3 in hematopoietic stem cells facilitates helper innate lymphoid cell differentiation[J]. Front Immunol, 2019, 3(10): 510-510.
[9]	Wong SH, Walker JA, Jolin HE, et al. Transcription factor RORα is critical for nuocyte development[J]. Nat Immunol, 2012, 13(3): 229-236. doi: 10.1038/ni.2208
[10]	Spooner CJ, Lesch J, Yan D, et al. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1[J]. Nat Immunol, 2013, 14(12): 1229-1236. doi: 10.1038/ni.2743
[11]	Yang Q, Monticelli LA, Saenz SA, et al. T cell factor 1 is required for group 2 innate lymphoid cell generation[J]. Immunity, 2013, 38(4): 694-704. doi: 10.1016/j.immuni.2012.12.003
[12]	Christina CA, Goplen NP, Zafar I, et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33[J]. J Allergy Clin Immunol, 2015, 136(1): 59-68. doi: 10.1016/j.jaci.2014.11.037
[13]	Barlow JL, Peel S, Fox J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes(type 2 innate lymphoid cells)and airway contraction[J]. J Allergy Clin Immunol, 2013, 132(4): 933-941. doi: 10.1016/j.jaci.2013.05.012
[14]	Barlow JL, Bellosi A, Hardman CS, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity[J]. J Allergy Clin Immunol, 2012, 129(1): 191-198. doi: 10.1016/j.jaci.2011.09.041
[15]	Alshami A, Spolski R, Kelly J, et al. A role for TSLP in the development of inflammation in an asthma model[J]. J Exp Med, 2005, 202(6): 829-839. doi: 10.1084/jem.20050199
[16]	Meylan F, Hawley ET, Barron L, et al. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells[J]. Mucosal Immunol, 2014, 7(4): 958-968. doi: 10.1038/mi.2013.114
[17]	Yu X, Pappu R, Ramirez-Carrozzi V, et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers[J]. Mucosal Immunol, 2014, 7(3): 730-740. doi: 10.1038/mi.2013.92
[18]	Ferdinand JR, Richard AC, Meylan F, et al. Cleavage of TL1A differentially regulates its effects on innate and adaptive immune cells[J]. J Immunol, 2018, 200(4): 1360-1369. doi: 10.4049/jimmunol.1700891
[19]	Maazi H, Patel N, Sankaranarayanan I, et al. ICOS: ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity[J]. Immunity, 2015, 42(3): 538-551. doi: 10.1016/j.immuni.2015.02.007
[20]	Salimi M, Barlow JL, Saunders SP, et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis[J]. J Exp Med, 2013, 210(13): 2939-2950. doi: 10.1084/jem.20130351
[21]	Doherty TA, Khorram N, Lund S, et al. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates Th2 cytokine production[J]. J Allergy Clin Immunol, 2013, 132(1): 205-213. doi: 10.1016/j.jaci.2013.03.048
[22]	Lund SJ, Portillo A, Cavagnero K, et al. Leukotriene C4 potentiates IL-33-Induced group 2 innate lymphoid cell activation and lung inflammation[J]. J Immunol, 2017, 199(3): 1096-1104. doi: 10.4049/jimmunol.1601569
[23]	Xue L, Salimi M, Panse I, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells[J]. J Allergy Clin Immunol, 2014, 133(4): 1184-1194. doi: 10.1016/j.jaci.2013.10.056
[24]	Maric J, Ravindran A, Mazzurana L, et al. Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation[J]. J Allergy Clin Immunol, 2019, 143, (6): 2202-2214. doi: 10.1016/j.jaci.2018.10.069
[25]	Zhou W, Toki S, Zhang J, et al. Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses[J]. Am J Respir Crit Care Med, 2016, 193(1): 31-42. doi: 10.1164/rccm.201410-1793OC
[26]	Barnig C, Cernadas M, Dutile S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma[J]. Sci Transl Med, 2013, 5(1): 174-174.
[27]	Lu X, Fu H, Han F, et al. Lipoxin A4 regulates PM2.5-induced severe allergic asthma in mice via the Th1/Th2 balance of group 2 innate lymphoid cells[J]. J Thorac Dis, 2018, 10(3): 1449-1459. doi: 10.21037/jtd.2018.03.02
[28]	Krishnamoorthy N, Burkett PR, Dalli J, et al. Cutting edge: Maresin-1 Engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation[J]. J Immunol, 2015, 194(3): 863-867. doi: 10.4049/jimmunol.1402534
[29]	Laffont S, Blanquart E, Savignac M, et al. Androgen signaling negatively controls group 2 innate lymphoid cells[J]. J Exp Med, 2017, 214(6): 1581-1592. doi: 10.1084/jem.20161807
[30]	Singh PB, Pua HH, Happ HC, et al. MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation[J]. J Exp Med, 2017, 214(12): 3627-3643. doi: 10.1084/jem.20170545
[31]	Johansson K, Malmhäll C, Ramos-Ramírez P, et al. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation[J]. J Allergy Clin Immunol, 2017, 139(3): 1007-1016. doi: 10.1016/j.jaci.2016.06.035
[32]	Talbot S, Abdulnour RE, Burkett PR, et al. Silencing nociceptor neurons reduces allergic airway inflammation[J]. Neuron, 2015, 87(2): 341-354. doi: 10.1016/j.neuron.2015.06.007
[33]	Cardoso V, Chesné J, Ribeiro H, et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U[J]. Nature, 2017, 549(7671): 277-281. doi: 10.1038/nature23469
[34]	Wallrapp A, Riesenfeld SJ, Burkett PR, et al. Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation[J]. Immunol Rev, 2018, 286(1): 53-73. doi: 10.1111/imr.12702
[35]	Shin YS, Jung, CG, Park HS, et al. Prevalence and clinical characteristics of local allergic rhinitis to house dust mites[J]. Curr Opin Allergy Clin Immunol, 2018, 18(1): 10-15. doi: 10.1097/ACI.0000000000000413
[36]	Doherty TA, Scott D, Walford HH, et al. Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84[J]. J Allergy Clin Immunol, 2014, 133(4): 1203-1205. doi: 10.1016/j.jaci.2013.12.1086
[37]	Lao-Araya M, Steveling E, Scadding GW, et al. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy[J]. J Allergy Clin Immunol, 2014, 134(5): 1193-1195. doi: 10.1016/j.jaci.2014.07.029
[38]	Fan D, Wang X, Wang M, et al. Allergen-dependent differences in ILC2 s frequencies in patients with allergic rhinitis[J]. Allergy Asthma Immunol Res, 2016, 8(3): 216-222. doi: 10.4168/aair.2016.8.3.216
[39]	Zhong H, Fan XL, Yu QN, et al. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis[J]. Clin Immunol, 2017, 183(2): 293-299.
[40]	Bartemes KR, Kephart GM, Fox SJ, et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma[J]. J Allergy Clin Immunol, 2014, 134(3): 671-678. doi: 10.1016/j.jaci.2014.06.024
[41]	Lin L, Dai F, Wei JJ, et al. Allergic inflammation is exacerbated by allergen-induced type 2 innate lymphoid cells in a murine model of allergic rhinitis[J]. Rhinology, 2017, 55(4): 339-347. doi: 10.4193/Rhin17.065
[42]	Lin L, Chen Z, Wei JJ, et al. CD4⁺T cells induce productions of IL-5 and IL-13 through MHCⅡ on ILC2 s in a murine model of allergic rhinitis[J]. Auris Nasus Larynx, 2019, 46(4): 533-541. doi: 10.1016/j.anl.2018.12.004
[43]	Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function[J]. Science, 2007, 316(4): 608-611.